Morgan Stanley Reaffirms “Buy” Rating on Ultragenyx Pharmaceutical (RARE) with $55 PT
The analyst’s bullish stance stemmed from Ultragenyx Pharmaceutical Inc.’s (NASDAQ:RARE) strong financial position, alongside its pivotal late-stage pipeline.
Insider Monkey Blog
TD Cowen Reiterates “Buy” Rating on Vaxcyte (PCVX) With $50 PT
The analyst cited positive Phase II data from the company’s VAX-24 infant vaccine trials.
H.C. Wainwright Remains Bullish on Legend Biotech (LEGN), Cites Solid Growth Trajectory for CARVYKTI Therapy
Discussing the company’s robust growth trajectory for its CARVYKTI therapy, he pointed toward the therapy’s rising clinical potential.
Canaccord Genuity Remains Bullish on Strategy (MSTR), Cites Bitcoin Yield Strategy as Key Growth Driver
On November 3, 2025, Canaccord Genuity reiterated its “Buy” rating on Strategy Inc. (NASDAQ:MSTR), while raising its price target from $464 to $474.
Goldman Sachs Bullish on Amicus Therapeutics (FOLD) Following Q3 2025 Results
The revision follows the company’s performance in the third quarter, marked by the first positive GAAP net income and solid revenue execution.
RBC Capital Raises PT on Ocular Therapeutix (OCUL) to $24 Amid Solid Growth Trajectory
The revised target was attributed to the company’s strong execution in its SOL-1 wet age-related macular degeneration (wAMD) superiority study.
Clear Street Raises PT on Beam Therapeutics (BEAM) to $37 Following Q3 Results
The revised target reflected the company’s robust performance in the third quarter of 2025.
Chime Financial (CHYM) Surpasses Its Guidance for Q3 2025, Reports 29% YoY Revenue Growth
This quarter surpassed the company’s guidance, helping Chime Financial, Inc.
RBC Capital Remains Bullish on Bread Financial Holdings (BFH) Amid Stable Outlook
On October 24, 2025, RBC Capital raised its price target on Bread Financial Holdings, Inc. (NYSE:BFH) from $64 to $70, maintaining a “Sector Perform” rating.
Jefferies Remains Bullish on Vale S.A. (VALE) Following Strong Q3 Results
On November 3, 2025, Jefferies raised its price target on Vale S.A. (NYSE:VALE) from $14 to $15, while maintaining a “Buy” rating.
Keefe, Bruyette & Woods Remains Bullish on Lincoln National Corporation (LNC) Following Q3 Results
Meanwhile, on October 30, 2025, Lincoln National Corporation (NYSE:LNC) released its Q3 results, marked by steady progress in strengthening its balance sheet, diversifying its...
Bank of America’s Akamine Remains Bearish on APA Corporation (APA), Cites High Operating Costs
On November 6, 2025, Bank of America Securities’ analyst Kalei Akamine maintained his “Sell” rating on APA Corporation (NASDAQ:APA) with a $20 price target.
UBS Maintains Neutral Stance on Bank OZK (OZK), Cites Mixed Credit Results
On October 28, 2025, UBS reduced its price target on Bank OZK (NASDAQ:OZK) from $57 to $50, while reiterating its “Neutral” rating.
The Western Union Company (WU) Introduces Its “Beyond” Strategy, Outlines Its Digital-First Expansion Plan
Western Union introduced its “Beyond” strategy at Investor Day in New York on November 6, 2025.
Roth Capital Remains Bullish on SM Energy (SM) Following Civitas Announcement
On November 4, 2025, Roth Capital reduced its price target on SM Energy Company (NYSE:SM) from $33 to $28, while reiterating its “Buy” rating.
Wolfe Research Sees Limited Upside for Civitas Resources, Inc. (CIVI) Following SM Energy Merger Announcement
On November 4, 2025, Wolfe Research downgraded Civitas Resources (NYSE:CIVI) from “Outperform” to “Peer Perform.” The investment firm’s revised rating reflects limited...
Morgan Reiterates Its Bullish Stance on Voya Financial (VOYA) Following Q3 2025 Results
This update followed Voya Financial, Inc.’s (NYSE:VOYA) Q3 2025 results announcement on November 4, 2025.
BofA Remains Neutral on Bristol-Myers Squibb Company (BMY), Expects Low Single-Digit Growth in the Long Term
On November 3, 2025, BofA raised its price target on Bristol-Myers Squibb Company (NYSE:BMY) from $50 to $52, reiterating its “Neutral” rating.
Oppenheimer’s Horan Sees a Challenging Five-Year Outlook on Comcast Corporation (CMCSA)
On November 3, 2025, Oppenheimer’s Timothy Horan downgraded Comcast Corporation (NASDAQ:CMCSA) from “Outperform” to “Perform,” removing his $38 price target.
10 Stocks Beating the Market with Eye-Popping Gains
Ten stocks kicked off Monday’s trading leading the charge, in line with the overall market optimism, as investors cheered the looming end of a government shutdown, while taking...
Jefferies Remains Positive on Keurig Dr Pepper (KDP), Sees Investor Confidence Returning
Keurig Dr Pepper Inc. (NASDAQ:KDP) is one of the best dividend stocks to buy.
Bernstein Remains Bullish on Dollar General (DG), Maintains Buy Call
Dollar General Corporation (NYSE:DG) is one of the best dividend stocks to buy.
Morgan Stanley Sees Growth Ahead for Starbucks (SBUX), Keeps Buy Rating and $105 PT
Starbucks Corporation (NASDAQ:SBUX) is one of the best dividend stocks to buy.
Kroger (KR) Expands AI and Delivery Capabilities Through Instacart Partnership
The Kroger Co. (NYSE:KR) is one of the best dividend stocks to buy.
Freedom Capital Markets Maintains Hold Rating on Pepsi Amid Modest Growth Outlook
PepsiCo, Inc. (NASDAQ:PEP) is one of the best dividend stocks to buy.
BofA Reiterates Buy Call on Coca-Cola (KO), Lifts PT to $80
The Coca-Cola Company (NYSE:KO) is one of the best dividend stocks to buy.
Parents Sue Procter & Gamble (PG) Over Kids’ Crest Toothpaste, Claim Packaging Misleads Consumers
The Procter & Gamble Company (NYSE:PG) is one of the best dividend stocks to buy.
Oppenheimer Remains Positive on Costco (COST), Names it a ‘Top Pick’
Costco Wholesale Corporation (NASDAQ:COST) is one of the best dividend stocks to buy.
Is Walmart (WMT) One of the Best Dividend Stocks to Buy?
Walmart Inc. (NYSE:WMT) is one of the best dividend stocks to buy.
Stifel Maintains a Buy Rating on Philip Morris (PM), Sets Target at $180
Philip Morris International Inc. (NYSE:PM) is one of the best dividend stocks to buy.
Is NVIDIA Corporation (NVDA) The Most Profitable Semiconductor Stock to Buy Now?
NVIDIA Corporation (NASDAQ:NVDA) is among the most profitable semiconductor stocks to buy.
15 Best Dividend Growth Stocks to Buy Now
Dividends are a way for companies to share a portion of their profits with investors.
Rithm Capital Corp. (RITM) Reports Strong Liquidity Position in Q3 2025
On October 30, 2025, Rithm Capital (NYSE:RITM) reported its Q3 results.
Hedge Fund and Insider Trading News: Izzy Englander, Lauren Taylor Wolfe, Carl Icahn, Ken Griffin, Philippe Laffont, NBT Bancorp Inc (NBTB), and More
You may be concerned about the recent declines in AI stocks such as NVDA.
10 Most Profitable Semiconductor Stocks to Buy
The semiconductor industry is one of the industries that remains in the spotlight for its importance in the AI supply chain.
Crypto vs. Cash: Which Is the Better Way to Pay Online in 2025?
When it comes to paying online in 2025, the choice often comes down to crypto or cash—two completely different approaches to spending.
NVIDIA Corporation (NVDA) Rallied On Heightened Investor Confidence In AI Infrastructure Expansion
Baron Funds, an investment management company, released its “Baron Technology Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Atlassian Corporation (TEAM) Declined Despite Solid Results And Guidance
Baron Funds, an investment management company, released its “Baron Technology Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Do You Have Conviction in the Long-Term Growth of Broadcom (AVGO)?
Baron Funds, an investment management company, released its “Baron Technology Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Baron Technology Fund’s Q3 2025 Investor Letter
Baron Funds, an investment management company, released its “Baron Technology Fund” third-quarter 2025 investor letter.
Should You Invest in Loar Holdings (LOAR)?
Baron Funds, an investment management company, released its “Baron Asset Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
StubHub Holdings (STUB) Fell Following the IPO
Baron Funds, an investment management company, released its “Baron Asset Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Amphenol Corporation (APH) Rose with Increasing Expectations for Data Center Spending
Baron Funds, an investment management company, released its “Baron Asset Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why IDEXX Laboratories (IDXX) Surged in Q3
Baron Funds, an investment management company, released its “Baron Asset Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Baron Asset Fund’s Q3 205 Investor Letter
Baron Funds, an investment management company, released its “Baron Asset Fund” third-quarter 2025 investor letter.
Greenhaven Road Capital’s Strategic Perspective on PAR Technologies (PAR)
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Greenhaven Road Capital’s Updates on Kingsway Financial (KFS)
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Greenhaven Road Capital Doubled Its Holdings in Hagerty (HGTY)
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Do You Believe in Upside Potential of KKR (KKR)?
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center
